Bectas Therapeutics, Inc.

CIK 2038826 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bectas Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 8, 2025D/A0002038826-25-000002
Oct 9, 2024D0002038826-24-000001